Rizg, W.Y.; Naveen, N.R.; Kurakula, M.; Safhi, A.Y.; Murshid, S.S.; Mushtaq, R.Y.; Abualsunun, W.A.; Alharbi, M.; Bakhaidar, R.B.; Almehmady, A.M.;
et al. Augmentation of Antidiabetic Activity of Glibenclamide Microspheres Using S-Protected Okra Powered by QbD: Scintigraphy and In Vivo Studies. Pharmaceuticals 2022, 15, 491.
https://doi.org/10.3390/ph15040491
AMA Style
Rizg WY, Naveen NR, Kurakula M, Safhi AY, Murshid SS, Mushtaq RY, Abualsunun WA, Alharbi M, Bakhaidar RB, Almehmady AM,
et al. Augmentation of Antidiabetic Activity of Glibenclamide Microspheres Using S-Protected Okra Powered by QbD: Scintigraphy and In Vivo Studies. Pharmaceuticals. 2022; 15(4):491.
https://doi.org/10.3390/ph15040491
Chicago/Turabian Style
Rizg, Waleed Y., N. Raghavendra Naveen, Mallesh Kurakula, Awaji Y. Safhi, Samar S. Murshid, Rayan Y. Mushtaq, Walaa A. Abualsunun, Majed Alharbi, Rana B. Bakhaidar, Alshaimaa M. Almehmady,
and et al. 2022. "Augmentation of Antidiabetic Activity of Glibenclamide Microspheres Using S-Protected Okra Powered by QbD: Scintigraphy and In Vivo Studies" Pharmaceuticals 15, no. 4: 491.
https://doi.org/10.3390/ph15040491
APA Style
Rizg, W. Y., Naveen, N. R., Kurakula, M., Safhi, A. Y., Murshid, S. S., Mushtaq, R. Y., Abualsunun, W. A., Alharbi, M., Bakhaidar, R. B., Almehmady, A. M., Salawi, A., Al Fatease, A., & Hosny, K. M.
(2022). Augmentation of Antidiabetic Activity of Glibenclamide Microspheres Using S-Protected Okra Powered by QbD: Scintigraphy and In Vivo Studies. Pharmaceuticals, 15(4), 491.
https://doi.org/10.3390/ph15040491
